Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2017-12-01
2019-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Impact of an Antibiotic Stewardship Program in a Neonatal Intensive Care Unit
NCT04039152
Bacteriological Profile and Antibiotic Sensitivity in Neonatal Intensive Care Unit At Assuit University Children Hospital
NCT06891768
Effect of Video Camera Monitoring Feedback on Hand Hygiene Compliance and Infections in NICU
NCT04053257
Prevention of Nosocomial Bacteremia Among Zambian Neonates
NCT02386592
Risks and Outcomes Among COVID-19 Patients Admitted to Assiut University Hospitals.
NCT04860245
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Nosocomial infections are common, and may be serious or fatal. Some are unavoidable but doctors' duty of care to their patients extends to fundamental matters such as basic hygiene, which may prevent patients becoming infected, and avoidance of unnecessary antibiotics, to discourage development of resistance Health care-associated infections (HC-AIs) are a major cause of morbidity and mortality in neonatal intensive care units (NICUs) and lead to increases in hospital length of stay and treatment cost. Higher nosocomial infection incidence in NICUs was related to longer duration of hospital stay, and invasive interventions and medical treatments. HC-AIs, especially device-associated health care-associated infections (DA-HAIs), were also common in newborns because of their insufficient immune system and mechanical barriers, as well as lack of protective flora
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Neonates who admitted for more than 48 hours
Exclusion Criteria
2. Neonates who admitted for less than 48 hours.
3. Neonates who admitted for infection reasons as (pneumonia, MAS, AGE and skin infection).
4. Neonates with potentially infection (PROM, chorioamnionitis, TOF)
5. Neonates with congenital infections
1 Day
28 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gehad Salah El-Den Mahmoud Mohammad
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gehad Salah El-Den Mahmoud Mohammad
Resident doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Asmaa Shorat, Professor
Role: STUDY_DIRECTOR
Assiut University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut university hospital
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HCAISN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.